Peking Union Medical College Hospital: Immunoglobulin G4-Related Disease trials
The registry lists 13 Immunoglobulin G4-Related Disease studies with Peking Union Medical College Hospital as lead sponsor. 5 are open to participants now and 0 have results posted.
Early Phase 1 2Phase 2 4Phase 3 2Phase 4 1No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Tripterygium Wilfordii Plus Prednisone for Active IgG4-Related DiseaseNot yet recruitingNCT07878585Phase 2
- A Randomized Controlled Study of the Efficacy and Safety of Lenalidomide in the Treatment of Active IgG4-related DiseaseRecruitingNCT07068165Phase 2/3
- Treatment Strategies for IgG4-RD Patients With Superficial Organ InvolvementRecruitingNCT05789030Not applicable
- National Registry of IgG4-RD in ChinaRecruitingNCT03023371
- A Prospective Cohort Study of IgG4RD in ChinaRecruitingNCT01670695
- Treatment Strategies in IgG4-RD Patients With Re-elevation of Serum IgG4 Level During Maintenance Remission PeriodStatus unknownNCT05974683Not applicable
- Belimumab Treatment for IgG4-related DiseaseStatus unknownNCT04660565Phase 4
- Circulating Plasmablast in Diagnosis and Relapse Prediction of IgG4-RDStatus unknownNCT04539197
- Characterizing IgG4-RD With 68Ga-FAPI PET/CTStatus unknownNCT04125511Early Phase 1
- Withdraw Drug in Stable IgG4-Related DiseaseStatus unknownNCT04124861Not applicable
- Study of Treatment Response on IgG4 Related Disease (IgG4RD)Status unknownNCT02458196Phase 2
- Glucocorticoids in Patients With IgG4-RDStatus unknownNCT01758393Phase 2/3
- 18F-FDG PET/CT for IgG4-Related DiseaseStatus unknownNCT01665196Early Phase 1